Stephanie Price
Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".
Stephanie Price · page 71
- Cultivation
Bophelo secures EU GACP compliance for cannabis exports
The certification allows Bophelo to export to international markets.
- Uncategorized
Tenacious Labs CEO discusses its acquisition of Press Pause
Tenacious Labs aims to bring Press Pause’s female-focused products to the UK to drive international growth.
- CBD Market
SEED Innovations invests £220,000 in Yooma Wellness
Yooma Wellness has submitted an application for the admission of its common shares to trading on AQSE.
- Companies
LYPHE Group announces revolutionary medical cannabis advisory board
The board will be chaired by Europe’s foremost medical cannabis expert Professor Mike Barnes.
- CBD Market
CBD company Alphagreen repeatedly beats market targets
The CBD market has switched to asset-light business models with strong scaling and global expansion opportunities rather than brands and companies with little revenue.
- Policy & Regulation
Landmark move sees cannabis trade organisation established in Jersey
The board has already been involved in providing counsel on an update to the Proceeds of Crime (Jersey) Law 1999.
- Companies
CanCoin appoints Scott de Mercado to Advisory Board
CanCoin says de Mercado’s expertise will allow it to further its mission of addressing key cannabis market problems in the European Union.
- Cultivation
CANNPRISMA receives Portuguese medical cannabis licence
The authorisation followed an on-site inspection by both PSP and INFARMED.
- CBD Market
180 Life Sciences selects CBD analogue for clinical development
The compound was selected based on a wide-ranging screen of derivatives of CBD and CBG made by cannabis pioneer Professor Mechoulam.
- Medical
Second medical cannabis flower launched by Curaleaf for UK market
Curaleaf aims to improve access and affordability for UK patients with its new products.
- CBD Market
Voyager establishes physical store for underserved UK CBD consumers
The physical store complements Voyager’s existing online sales and growing number of trade accounts.
- Cultivation
Hellenic Dynamics on track to be first medical cannabis cultivator on LSE
UK SPAC has submitted a first draft of the prospectus to the FCA and has made an application in respect of a Standard Listing.
